Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis that preferentially affects
medium-sized vessels. The idiopathic form has become rare. Its treatment relies on …

Abstract Purpose of Review Rituximab has transformed the treatment of B-cell malignancies
and rheumatoid arthritis in the past 2 decades. More recently, this anti-CD20 monoclonal …

Purpose To identify the macular retinal layer thickness changes in polyarteritis nodosa
(PAN) patients without pathological findings appearing in color fundus photography (CFP) …

Glucocorticoids are the cornerstone of therapy for all forms of vasculitis. However,
glucocorticoid treatment carries with it the risk of glucocorticoid toxicity. Recent research …

Background: Cutaneous polyarteritis nodosa (cPAN) is a form of medium-sized vessel
necrotizing vasculitis. It is a rare, skin-limited variant of polyarteritis nodosa, characterized by …

Dirk M. Elston, MD Charleston, South Carolina In this issue of the JAAD, Stewart et al
describe a retrospective case series of 16 patients with cutaneous polyarteritis nodosa …

Antimalarial agents have been used to treat various autoimmune rheumatic diseases for
over a century. Hydroxychloroquine is a safe, effective and inexpensive antimalarial drug …

The ongoing debate on whether lymphocytic thrombophilic arteritis (LTA) is a separate
disease or a type of polyarteritis nodosa (PAN) has yet to be settled. In this study, we …

Polyarteritis nodosa (PAN) is a systemic necrotising vasculitis with a poor prognosis,
characterised by inflammation and necrosis of medium-sized arteries. PAN patients can …

Introduction: Small artery disease caused by neutrophils and immune-mediated is known as
leucocytoclastic vasculitis (LCV). Clinically, it manifests as palpable, asymptomatic purpuric …